Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
+900.00%
Window
Jun 23, 2025 → Jun 5, 2026
Coverage: 240 bars · Jun 23, 2025 → Jun 5, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
South American Gold Corp. (SAGD) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 900.0% across the available one-year price window (Jun 23, 2025 → Jun 5, 2026). Baseline metrics include revenue growth of +144.2%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue +144.2%, EPS 0.0%, free cash flow +42.0% with operating margin -47.7% and ROIC 0.8%. Valuation is more restrained than many high-expectation growth names at price/sales 0.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SAGD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SAGD
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SAGD Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SAGD and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
-100.0% YoY
FY Net Income
-$206.0K
+20.5% YoY
Free Cash Flow
-$442.8K
-168.7% YoY
Revenue Growth
+144.2%
EPS Growth
+0.0%
Gross Margin
100.0%
Net Margin
-595.3%
Income statement
USD
| Metric | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|
| Revenue | 20K | 8K | 26K | 8K | 0 |
| Gross Profit | 20K | 8K | 26K | 0 | -125 |
| Operating Income | -10K | -63K | -98K | -75K | -112K |
| EBITDA | -78K | -125K | -232K | -152K | -131K |
| Net Income | -119K | -125K | -339K | -259K | -206K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2018 | 2017 | 2016 | 2013 | 2012 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2K | 0 | 0 | 118 | 87 |
| Total Assets | 25K | 35K | 8K | 1K | 2K |
| Total Liabilities | 2M | 1M | 962K | 466K | 264K |
| Shareholder Equity | -2M | -1M | -954K | -464K | -262K |
| Total Debt | 346K | 373K | 141K | 58K | 0 |
| Net Debt | 344K | 373K | 141K | 58K | -87 |
Cash flow positioning
Latest Full Year
Operating Cash Flow
443K
-170.7% YoY
Capital Expenditures
0
+100.0% YoY
Free Cash Flow
443K
-168.7% YoY
Key ratios
Gross Margin
100.0%
Operating Margin
-47.7%
Net Margin
-595.3%
ROE
8.1%
Debt / Equity
-0.22x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.